FSB Premier Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$339K Sell
5,429
-632
-10% -$39.9K 0.09% 190
2026
Q2
$349K Sell
6,061
-377
-6% -$21.6K 0.1% 186
2026
Q1
$390K Buy
+6,438
New +$375K 0.12% 160
2022
Q1
– Sell
-2,655
Closed -$165K – 176
2021
Q4
$165K Buy
+2,655
New +$156K 0.07% 137

Other funds holding BMY

FSB Premier Wealth Management's BMY Position: Q3 2026 in Review

FSB Premier Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 10% in Q3 2026, selling an estimated $39.9K and leaving 5,429 shares worth $339K. The position accounts for 0.09% of the portfolio, ranked #190.

FSB Premier Wealth Management first reported a position in BMY in Q4 2021 and has held it in 4 quarters since. The position peaked at $390K in Q1 2026. 2,568 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • FSB Premier Wealth Management held 5,429 shares of Bristol-Myers Squibb worth $339K as of Q3 2026.
  • FSB Premier Wealth Management sold 632 Bristol-Myers Squibb shares in Q3 2026, an estimated $39.9K.
  • Bristol-Myers Squibb made up 0.09% of FSB Premier Wealth Management's portfolio in Q3 2026, its #190 holding.
  • FSB Premier Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 4 quarters since.
  • FSB Premier Wealth Management's Bristol-Myers Squibb position peaked at $390K in Q1 2026.
  • 2,568 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on FSB Premier Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.